Clover Health Investments, Corp CLOV

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

• GlobeNewswire Inc. 24 sept

  UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors

  Clover Health announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D. to its Board of Directors, effective immediately. Senator Torricelli will serve on the Audit Committee while Dr. Miller will serve on the Clinical Committee. The appointments fill two board vacancies and bring the board to nine directors. Both appointees bring extensive experience in healthcare policy, Medicare Advantage, clinical practice, and business strategy.

  

• GlobeNewswire Inc. 24 sept

  Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors

  Clover Health announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., to its Board of Directors, effective immediately. Torricelli will serve on the Audit Committee while Dr. Miller will serve on the Clinical Committee. Both appointments bring complementary expertise in healthcare policy, Medicare Advantage, clinical practice, and business strategy to strengthen the company's governance and execution.

  

• The Motley Fool 31 jul

  Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.

  Clover Health CEO Andrew Toy sold 62,711 shares worth ~$292,860 on July 15, 2026, to cover tax withholding obligations from RSU vesting. The sale is non-discretionary and doesn't reflect a change in conviction. Toy retains a $44.68 million stake (~2% ownership). The stock has gained 57% over the past year but dropped 20% in July following a data breach disclosure. Q2 earnings are expected in early August.

  

• The Motley Fool 6 jul

  Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.

  Clover Health CEO Andrew Toy sold 313,476 shares worth $1.67 million on July 1, 2026, representing a 3.16% reduction in his direct holdings. The sale was a non-discretionary tax withholding event tied to RSU vesting, not a signal of lost confidence. Toy retains 9.6 million shares, maintaining significant alignment with shareholders. The sale comes amid strong company performance, including a court-mandated Medicare rating upgrade and 51% year-over-year membership growth in Q1 2026.

  

• The Motley Fool 27 jun

  A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.

  Clover Health board member Dr. Carladenise Armbrister Edwards sold 67,160 shares (~$230,000) on May 18, 2026, reducing her direct holdings by 19%. The sale occurred during muted stock performance, but the director has not sold additional shares despite the stock subsequently reaching a 52-week high of $5.49 following a favorable court ruling and strong Q1 earnings with 62% revenue growth.